Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Orsolya Rideg"'
Autor:
Orsolya Rideg, Tímea Dergez, Kornélia Farkas, Krisztina Kovács, Endre Kálmán, Tamás Tornóczky, Angéla Oszter
Publikováno v:
Vaccines, Vol 10, Iss 5, p 748 (2022)
Identification of HPV infection is usually performed on cytological specimens, despite the often transient virus types. HPV profile analysis of pathologically confirmed lesions can also be performed on formalin-fixed paraffin-embedded (FFPE) cone sam
Externí odkaz:
https://doaj.org/article/7c0b7262f996449cb25fac3527633b11
Autor:
Orsolya Rideg, Angéla Oszter, Evelin Makk, Endre Kálmán, Kornélia Farkas, Tamás Tornóczky, Krisztina Kovács
Publikováno v:
Vaccines, Vol 9, Iss 6, p 604 (2021)
External anogenital warts (EGW) are primarily associated with the low-risk human papillomavirus (HPV) genotypes 6 and 11, though coinfection with other low-risk and oncogenic high-risk HPV genotypes also occurs. Although there have been many studies
Externí odkaz:
https://doaj.org/article/48c89f2a13224105af61a406451db718
Autor:
Endre Kálmán, Angéla Oszter, Kornélia Farkas, Krisztina Kovacs, Orsolya Rideg, Evelin Makk, Tamás Tornóczky
Publikováno v:
Vaccines; Volume 9; Issue 6; Pages: 604
Vaccines
Vaccines, Vol 9, Iss 604, p 604 (2021)
Vaccines
Vaccines, Vol 9, Iss 604, p 604 (2021)
External anogenital warts (EGW) are primarily associated with the low-risk human papillomavirus (HPV) genotypes 6 and 11, though coinfection with other low-risk and oncogenic high-risk HPV genotypes also occurs. Although there have been many studies
Autor:
Orsolya Rideg, Margit Tőkés-Füzesi, Péter Kustán, Gábor L. Kovács, Tihamer Molnar, Istvan Ruzsics
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Margit TÅkés-Füzesi,1 István Ruzsics,2 Orsolya Rideg,3 Péter Kustán,1 Gábor L Kovács,1,4 Tihamér Molnár5 1Department of Laboratory Medicine, University of Pécs, Medical School, Pécs, Hungary; 21st Department of Internal Medicine, Divisi
Background: External anogenital warts (EGW) are primarily associated with the low-risk Human papillomavirus (HPV) genotype 6 and 11, though coinfection with other low-risk and oncogenic high-risk HPV genotypes also occurs. Though the many studies abo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09eac2904c200603edc32afbdaac06f7
https://doi.org/10.21203/rs.3.rs-153810/v1
https://doi.org/10.21203/rs.3.rs-153810/v1
Autor:
Szücs F, Fittler A, Péter Osváth, Lajos Botz, Orsolya Rideg, Sándor Fekete, Attila Miseta, Háber A, Gábor L. Kovács
Publikováno v:
Pharmacopsychiatry. 46:156-160
The insufficient response of patients to antidepressant medications may result from several factors, including altered drug metabolism. CYP2D6 genotyping may help assess the possible factors that contribute to difficult-to-treat depression. The aim o
Autor:
Orsolya Rideg, Tünde Pintér, Dániel Aradi, András Vorobcsuk, Tamás Magyarlaki, András Komócsi, Balázs Magyari, Iván Horváth, Attila Kónyi
Publikováno v:
European Journal of Clinical Investigation. 42:384-392
Eur J Clin Invest 2012; 42 (4): 384–392 Abstract Background The GRAVITAS trial showed that 150 mg clopidogrel did not improve outcome in patients with high on-clopidogrel platelet reactivity (HPR) screened by the VerifyNow assay. We aimed to determ
Autor:
Reka Varnai, Ferenc Szücs, Orsolya Rideg, Gábor L. Kovács, Attila Miseta, Ágota Háber, Lajos Botz
Publikováno v:
Cell Biochemistry and Function. 29:562-568
Polymorphisms of CYP450 metabolizer enzymes and transport proteins play crucial roles in the inter-individual variability of drug efficiency. The aim of our study was to predict the frequency of functional variants of CYP2D6, CYP2C19 and ABCB1 genes
Publikováno v:
Interventional Medicine and Applied Science. 3:32-38
Clopidogrel is essential to prevent recurrent ischemic events in patients with acute coronary syndromes and after percutaneous coronary interventions (PCIs). However, platelet reactivity after clopidogrel treatment is not uniform, and high on-treatme
Autor:
András Komócsi, Iván Horváth, András Vorobcsuk, Orsolya Rideg, Victor L. Serebruany, Margit Tokes-Fuzesi, Tamás Magyarlaki, Dániel Aradi
Publikováno v:
American Heart Journal. 160:543-551
A growing number of observational studies suggest that high on-clopidogrel platelet reactivity (HPR) is associated with recurrent thrombotic events after percutaneous coronary intervention. We aimed to perform an updated systematic review and meta-an